Diagnostic value of CD4/CD8 ratio in induced sputum (IS) in interstitial lung disease (ILD)

T. Boikaner, J. Greif, Y. Schwartz, A. Man, E. Fireman (Tel-Aviv, Israel)

Source: Annual Congress 2004 - Pathobiological and clinical investigations in interstitial lung diseases
Session: Pathobiological and clinical investigations in interstitial lung diseases
Session type: Oral Presentation
Number: 195
Disease area: Interstitial lung diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Boikaner, J. Greif, Y. Schwartz, A. Man, E. Fireman (Tel-Aviv, Israel). Diagnostic value of CD4/CD8 ratio in induced sputum (IS) in interstitial lung disease (ILD). Eur Respir J 2004; 24: Suppl. 48, 195

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diagnostic value of induced sputum (IS) in interstitial lung disease (ILD)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Safety of sputum induction (SI) in interstitial lung disease (ILD)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Elevated apoptosis rate of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonitis (NSIP) – strong positive correlation with bronchoalvoelar lavage (BAL) neutrophil count.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020

Induced sputum (IS) in patients with interstitial lung disease (ILD) – comparison with bronchoalveolar lavage (BAL)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


CD8 BAL lymphocytosis differentiates usual interstitial pneumonia (UIP) from sarcoidosis (SA); correlation with clinical parameters
Source: Eur Respir J 2001; 18: Suppl. 33, 195s
Year: 2001

Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease
Source: Eur Respir J 2007; 30: Suppl. 51, 121s
Year: 2007

Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases
Source: Eur Respir J 2004; 24: 1000-1006
Year: 2004



Correlations between high resolution computed tomography (HRCT), pulmonary function tests (PFT), and bronchoalveolar lavage fluid (BALF) cellularity in the interstitial lung disease associated to collagen-vascular diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 195s
Year: 2001

A comparison of T lymphocytes (TLs) subpopulations in lung tissue and in bronchoalveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2004; 24: Suppl. 48, 43s
Year: 2004

Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009


The Gender-Age-Physiology (GAP) Index enhanced with KL-6 serum level for predicting disease progression in interstitial lung diseases (ILD).
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


BAL regulatory T cells (Tregs) are decreased in common variable immunodeficiency (CVID) with ILD
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013

The diagnostic value of bronchoalvolar lavage (BAL) in the diagnosis of peripheral lung cancer (PLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 253s
Year: 2003

Correlation between cellularity of bronchoalveolar lavage (BAL) and parameters of lung function (LF) in patients with sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 180s
Year: 2003

Broncholaveolar lavage (BAL) lymphocytes from patients with interstitial lung diseases (ILD) produce hepatocyte growth factor (HGF)
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009

Flow cytometry (FC) in examination of broncholaveolar lavage (BAL) in interstitial lung diseases (ILD). Presentation of 14 years‘ experience
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Is there any correlation between apoptosis of the cells from bronchoalveolar lavage fluid (BALF) and the progression of chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011

Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006


Immunocytological study of bronchioloalveolar lavage (BAL) in interstitial lung diseases (ILD) diagnosis
Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound
Year: 2018


Flow cytometry (FC) applied to bronchoalveolar lavage lymphocyte (L-BAL) analyses as auxiliary diagnostic tool in interstitial lung diseases (ILD)
Source: Eur Respir J 2003; 22: Suppl. 45, 226s
Year: 2003